Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03150758 · ClinicalTrials.gov registry record · NA

Intra-operative Assessment of Cavernosal Nerve Stimulus Threshold

A NA study, sponsored by Case Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
6
Enrollment target

NCT03150758: Completed NA study, sponsored by Case Comprehensive Cancer Center.

NCT03150758 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03150758, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

Erectile dysfunction persists in approximately 80% of men 1 year after prostatectomy. Various erectile rehabilitation strategies have not provided benefit. Electrical stimulation has been demonstrated to benefit neuroregeneration and the functional recovery of neuromuscular systems. Therefore, electrical stimulation of the cavernosal nerves during radical prostatectomy is being investigated for its potential development into a treatment aimed at improving recovery of erectile function after prostatectomy. This pilot study is intended to determine the threshold of electrical stimulation that results in penile erection, as defined by persistent intracavernosal pressure increase, such that future studies of sub-threshold stimulation may be pursued.

Primary Outcome

Median value of "maximum stimulation pattern men received prior to erection" in responders

Interventions

  • DEVICE 10Hz + 100 micro-seconds
  • DEVICE 10Hz + 200 micro-seconds
  • DEVICE 7Hz + 100 micro-seconds
  • DEVICE 7Hz + 200 micro-seconds

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2017-01-01
Est. Completion 2018-04-24
Phase NA
Case Comprehensive Cancer Center

407 total trials

What the finished NCT03150758 record still lists

NCT03150758 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 4 interventions - of which 10Hz + 100 micro-seconds is the first listed.

NCT03150758 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03150758 about?

NCT03150758 is a clinical study titled "Intra-operative Assessment of Cavernosal Nerve Stimulus Threshold". Erectile dysfunction persists in approximately 80% of men 1 year after prostatectomy. Various erectile rehabilitation strategies have not provided benefit. Electrical stimulation has been demonstrated to benefit neuroregeneration and the functional recovery of neuromuscular systems. Therefore, elect...

What is the current status of trial NCT03150758?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2017-01-01. Estimated completion is 2018-04-24.

What interventions are being tested in trial NCT03150758?

The interventions under investigation include: 10Hz + 100 micro-seconds (DEVICE), 10Hz + 200 micro-seconds (DEVICE), 7Hz + 100 micro-seconds (DEVICE), 7Hz + 200 micro-seconds (DEVICE).

Who is sponsoring clinical trial NCT03150758?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03150758's enrollment target sits among peer trials

6 1983rd of 2000 higher than 13 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03150758, the US trial registry maintained by the National Library of Medicine. NCT03150758 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.